nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—P-Glycoprotein Inhibitors—Vemurafenib—melanoma	0.586	1	CiPCiCtD
Cyclosporine—ABCC1—Vemurafenib—melanoma	0.0367	0.17	CbGbCtD
Cyclosporine—ABCC10—Docetaxel—melanoma	0.0326	0.151	CbGbCtD
Cyclosporine—ABCB1—melanoma	0.0304	1	CbGaD
Cyclosporine—ABCG2—Vemurafenib—melanoma	0.0246	0.114	CbGbCtD
Cyclosporine—ABCC1—Dactinomycin—melanoma	0.0244	0.113	CbGbCtD
Cyclosporine—ABCG2—Dactinomycin—melanoma	0.0163	0.0755	CbGbCtD
Cyclosporine—ABCC1—Docetaxel—melanoma	0.0126	0.0582	CbGbCtD
Cyclosporine—CYP3A4—Temozolomide—melanoma	0.00969	0.0448	CbGbCtD
Cyclosporine—ABCC2—Docetaxel—melanoma	0.00933	0.0431	CbGbCtD
Cyclosporine—ABCG2—Docetaxel—melanoma	0.00844	0.039	CbGbCtD
Cyclosporine—CYP2D6—Vemurafenib—melanoma	0.00835	0.0386	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.00623	0.0288	CbGbCtD
Cyclosporine—CYP3A7—Docetaxel—melanoma	0.00623	0.0288	CbGbCtD
Cyclosporine—ABCB1—Dactinomycin—melanoma	0.00589	0.0272	CbGbCtD
Cyclosporine—CYP3A4—Vemurafenib—melanoma	0.00531	0.0245	CbGbCtD
Cyclosporine—CYP3A5—Docetaxel—melanoma	0.00467	0.0216	CbGbCtD
Cyclosporine—ABCB1—Docetaxel—melanoma	0.00304	0.0141	CbGbCtD
Cyclosporine—CYP3A4—Docetaxel—melanoma	0.00182	0.00842	CbGbCtD
Cyclosporine—FKBP4—hair follicle—melanoma	0.00165	0.0604	CbGeAlD
Cyclosporine—CAMLG—hair follicle—melanoma	0.0015	0.055	CbGeAlD
Cyclosporine—PPIF—hair follicle—melanoma	0.00111	0.0405	CbGeAlD
Cyclosporine—PPP3CA—hair follicle—melanoma	0.00106	0.0388	CbGeAlD
Cyclosporine—PPIB—hair follicle—melanoma	0.00106	0.0386	CbGeAlD
Cyclosporine—FKBP4—eye—melanoma	0.000825	0.0301	CbGeAlD
Cyclosporine—PPID—retina—melanoma	0.000755	0.0276	CbGeAlD
Cyclosporine—CAMLG—retina—melanoma	0.000744	0.0272	CbGeAlD
Cyclosporine—FKBP4—skin of body—melanoma	0.000718	0.0262	CbGeAlD
Cyclosporine—PPIB—neck—melanoma	0.000709	0.0259	CbGeAlD
Cyclosporine—FKBP1B—head—melanoma	0.000708	0.0259	CbGeAlD
Cyclosporine—PPIA—eye—melanoma	0.000684	0.025	CbGeAlD
Cyclosporine—PPIA—retina—melanoma	0.000678	0.0248	CbGeAlD
Cyclosporine—PPID—mammalian vulva—melanoma	0.000604	0.0221	CbGeAlD
Cyclosporine—CAMLG—mammalian vulva—melanoma	0.000596	0.0218	CbGeAlD
Cyclosporine—PPIF—eye—melanoma	0.000554	0.0202	CbGeAlD
Cyclosporine—PPIF—retina—melanoma	0.000549	0.02	CbGeAlD
Cyclosporine—PPIA—mammalian vulva—melanoma	0.000543	0.0198	CbGeAlD
Cyclosporine—PPIB—eye—melanoma	0.000527	0.0193	CbGeAlD
Cyclosporine—PPP3CA—retina—melanoma	0.000525	0.0192	CbGeAlD
Cyclosporine—FKBP1B—lymph node—melanoma	0.000496	0.0181	CbGeAlD
Cyclosporine—PPIF—skin of body—melanoma	0.000482	0.0176	CbGeAlD
Cyclosporine—FKBP1A—neck—melanoma	0.000474	0.0173	CbGeAlD
Cyclosporine—FKBP4—head—melanoma	0.000468	0.0171	CbGeAlD
Cyclosporine—PPIB—skin of body—melanoma	0.000459	0.0168	CbGeAlD
Cyclosporine—PPIF—mammalian vulva—melanoma	0.000439	0.0161	CbGeAlD
Cyclosporine—PPID—head—melanoma	0.000432	0.0158	CbGeAlD
Cyclosporine—CAMLG—head—melanoma	0.000426	0.0156	CbGeAlD
Cyclosporine—PPP3CA—mammalian vulva—melanoma	0.000421	0.0154	CbGeAlD
Cyclosporine—PPIB—mammalian vulva—melanoma	0.000418	0.0153	CbGeAlD
Cyclosporine—ABCC1—hair follicle—melanoma	0.0004	0.0146	CbGeAlD
Cyclosporine—FKBP1A—eye—melanoma	0.000352	0.0129	CbGeAlD
Cyclosporine—FKBP1A—retina—melanoma	0.000349	0.0128	CbGeAlD
Cyclosporine—FKBP4—lymph node—melanoma	0.000328	0.012	CbGeAlD
Cyclosporine—PPIF—head—melanoma	0.000314	0.0115	CbGeAlD
Cyclosporine—FKBP1A—skin of body—melanoma	0.000306	0.0112	CbGeAlD
Cyclosporine—PPID—lymph node—melanoma	0.000303	0.0111	CbGeAlD
Cyclosporine—PPP3CA—head—melanoma	0.000301	0.011	CbGeAlD
Cyclosporine—PPIB—head—melanoma	0.000299	0.0109	CbGeAlD
Cyclosporine—CAMLG—lymph node—melanoma	0.000298	0.0109	CbGeAlD
Cyclosporine—FKBP1A—mammalian vulva—melanoma	0.00028	0.0102	CbGeAlD
Cyclosporine—PPIA—lymph node—melanoma	0.000272	0.00993	CbGeAlD
Cyclosporine—SLC10A1—head—melanoma	0.000256	0.00935	CbGeAlD
Cyclosporine—ABCC10—mammalian vulva—melanoma	0.000224	0.00818	CbGeAlD
Cyclosporine—PPIF—lymph node—melanoma	0.00022	0.00804	CbGeAlD
Cyclosporine—PPP3CA—lymph node—melanoma	0.000211	0.0077	CbGeAlD
Cyclosporine—PPIB—lymph node—melanoma	0.00021	0.00765	CbGeAlD
Cyclosporine—FKBP1A—head—melanoma	0.0002	0.00731	CbGeAlD
Cyclosporine—ABCC3—head—melanoma	0.000161	0.00588	CbGeAlD
Cyclosporine—ABCC1—mammalian vulva—melanoma	0.000158	0.00579	CbGeAlD
Cyclosporine—ABCB1—blood vessel—melanoma	0.000153	0.00559	CbGeAlD
Cyclosporine—FKBP1A—lymph node—melanoma	0.00014	0.00512	CbGeAlD
Cyclosporine—SLCO1A2—head—melanoma	0.000138	0.00504	CbGeAlD
Cyclosporine—ABCG2—mammalian vulva—melanoma	0.000131	0.00479	CbGeAlD
Cyclosporine—ABCC3—lymph node—melanoma	0.000113	0.00412	CbGeAlD
Cyclosporine—ABCC10—lymph node—melanoma	0.000112	0.0041	CbGeAlD
Cyclosporine—ABCC2—lymph node—melanoma	9.01e-05	0.00329	CbGeAlD
Cyclosporine—Alopecia—Dactinomycin—melanoma	8.79e-05	0.00127	CcSEcCtD
Cyclosporine—Visual impairment—Temozolomide—melanoma	8.67e-05	0.00125	CcSEcCtD
Cyclosporine—Flushing—Carmustine—melanoma	8.64e-05	0.00125	CcSEcCtD
Cyclosporine—Ill-defined disorder—Bleomycin—melanoma	8.61e-05	0.00124	CcSEcCtD
Cyclosporine—Anaemia—Bleomycin—melanoma	8.58e-05	0.00124	CcSEcCtD
Cyclosporine—Diarrhoea—Vemurafenib—melanoma	8.55e-05	0.00123	CcSEcCtD
Cyclosporine—Migraine—Docetaxel—melanoma	8.51e-05	0.00123	CcSEcCtD
Cyclosporine—Tinnitus—Temozolomide—melanoma	8.39e-05	0.00121	CcSEcCtD
Cyclosporine—Malaise—Bleomycin—melanoma	8.37e-05	0.00121	CcSEcCtD
Cyclosporine—Flushing—Temozolomide—melanoma	8.35e-05	0.0012	CcSEcCtD
Cyclosporine—Arrhythmia—Carmustine—melanoma	8.31e-05	0.0012	CcSEcCtD
Cyclosporine—Leukopenia—Bleomycin—melanoma	8.31e-05	0.0012	CcSEcCtD
Cyclosporine—Dizziness—Vemurafenib—melanoma	8.27e-05	0.00119	CcSEcCtD
Cyclosporine—Alopecia—Carmustine—melanoma	8.22e-05	0.00119	CcSEcCtD
Cyclosporine—Angiopathy—Temozolomide—melanoma	8.16e-05	0.00118	CcSEcCtD
Cyclosporine—Mental disorder—Carmustine—melanoma	8.15e-05	0.00118	CcSEcCtD
Cyclosporine—Mediastinal disorder—Temozolomide—melanoma	8.11e-05	0.00117	CcSEcCtD
Cyclosporine—Malnutrition—Carmustine—melanoma	8.1e-05	0.00117	CcSEcCtD
Cyclosporine—Cough—Bleomycin—melanoma	8.1e-05	0.00117	CcSEcCtD
Cyclosporine—ABCB1—retina—melanoma	8.08e-05	0.00295	CbGeAlD
Cyclosporine—Chills—Temozolomide—melanoma	8.07e-05	0.00116	CcSEcCtD
Cyclosporine—Ill-defined disorder—Dactinomycin—melanoma	8.03e-05	0.00116	CcSEcCtD
Cyclosporine—Anaemia—Dactinomycin—melanoma	8e-05	0.00115	CcSEcCtD
Cyclosporine—Vomiting—Vemurafenib—melanoma	7.95e-05	0.00115	CcSEcCtD
Cyclosporine—Alopecia—Temozolomide—melanoma	7.95e-05	0.00115	CcSEcCtD
Cyclosporine—ABCC1—lymph node—melanoma	7.93e-05	0.0029	CbGeAlD
Cyclosporine—Dry skin—Docetaxel—melanoma	7.92e-05	0.00114	CcSEcCtD
Cyclosporine—Chest pain—Bleomycin—melanoma	7.9e-05	0.00114	CcSEcCtD
Cyclosporine—Myalgia—Bleomycin—melanoma	7.9e-05	0.00114	CcSEcCtD
Cyclosporine—Abdominal pain upper—Docetaxel—melanoma	7.9e-05	0.00114	CcSEcCtD
Cyclosporine—Rash—Vemurafenib—melanoma	7.88e-05	0.00114	CcSEcCtD
Cyclosporine—Mental disorder—Temozolomide—melanoma	7.88e-05	0.00114	CcSEcCtD
Cyclosporine—Dermatitis—Vemurafenib—melanoma	7.88e-05	0.00114	CcSEcCtD
Cyclosporine—Headache—Vemurafenib—melanoma	7.83e-05	0.00113	CcSEcCtD
Cyclosporine—Malnutrition—Temozolomide—melanoma	7.83e-05	0.00113	CcSEcCtD
Cyclosporine—Breast disorder—Docetaxel—melanoma	7.81e-05	0.00113	CcSEcCtD
Cyclosporine—Discomfort—Bleomycin—melanoma	7.81e-05	0.00113	CcSEcCtD
Cyclosporine—Malaise—Dactinomycin—melanoma	7.81e-05	0.00113	CcSEcCtD
Cyclosporine—Cramp muscle—Docetaxel—melanoma	7.78e-05	0.00112	CcSEcCtD
Cyclosporine—Leukopenia—Dactinomycin—melanoma	7.75e-05	0.00112	CcSEcCtD
Cyclosporine—Dysgeusia—Temozolomide—melanoma	7.67e-05	0.00111	CcSEcCtD
Cyclosporine—Confusional state—Bleomycin—melanoma	7.64e-05	0.0011	CcSEcCtD
Cyclosporine—Vision blurred—Carmustine—melanoma	7.63e-05	0.0011	CcSEcCtD
Cyclosporine—Tremor—Carmustine—melanoma	7.59e-05	0.0011	CcSEcCtD
Cyclosporine—Oedema—Bleomycin—melanoma	7.57e-05	0.00109	CcSEcCtD
Cyclosporine—Anaphylactic shock—Bleomycin—melanoma	7.57e-05	0.00109	CcSEcCtD
Cyclosporine—Infection—Bleomycin—melanoma	7.53e-05	0.00109	CcSEcCtD
Cyclosporine—Anaemia—Carmustine—melanoma	7.49e-05	0.00108	CcSEcCtD
Cyclosporine—Dysphagia—Docetaxel—melanoma	7.47e-05	0.00108	CcSEcCtD
Cyclosporine—Agitation—Carmustine—melanoma	7.44e-05	0.00107	CcSEcCtD
Cyclosporine—Nausea—Vemurafenib—melanoma	7.43e-05	0.00107	CcSEcCtD
Cyclosporine—Thrombocytopenia—Bleomycin—melanoma	7.42e-05	0.00107	CcSEcCtD
Cyclosporine—Vision blurred—Temozolomide—melanoma	7.38e-05	0.00106	CcSEcCtD
Cyclosporine—Myalgia—Dactinomycin—melanoma	7.37e-05	0.00106	CcSEcCtD
Cyclosporine—Bronchospasm—Docetaxel—melanoma	7.35e-05	0.00106	CcSEcCtD
Cyclosporine—Tremor—Temozolomide—melanoma	7.33e-05	0.00106	CcSEcCtD
Cyclosporine—Discomfort—Dactinomycin—melanoma	7.28e-05	0.00105	CcSEcCtD
Cyclosporine—Ill-defined disorder—Temozolomide—melanoma	7.26e-05	0.00105	CcSEcCtD
Cyclosporine—Leukopenia—Carmustine—melanoma	7.25e-05	0.00105	CcSEcCtD
Cyclosporine—Anaemia—Temozolomide—melanoma	7.24e-05	0.00104	CcSEcCtD
Cyclosporine—Anorexia—Bleomycin—melanoma	7.22e-05	0.00104	CcSEcCtD
Cyclosporine—Agitation—Temozolomide—melanoma	7.19e-05	0.00104	CcSEcCtD
Cyclosporine—Angioedema—Temozolomide—melanoma	7.15e-05	0.00103	CcSEcCtD
Cyclosporine—Oedema—Dactinomycin—melanoma	7.06e-05	0.00102	CcSEcCtD
Cyclosporine—Malaise—Temozolomide—melanoma	7.06e-05	0.00102	CcSEcCtD
Cyclosporine—Vertigo—Temozolomide—melanoma	7.03e-05	0.00102	CcSEcCtD
Cyclosporine—Convulsion—Carmustine—melanoma	7.02e-05	0.00101	CcSEcCtD
Cyclosporine—Infection—Dactinomycin—melanoma	7.02e-05	0.00101	CcSEcCtD
Cyclosporine—Leukopenia—Temozolomide—melanoma	7.01e-05	0.00101	CcSEcCtD
Cyclosporine—Hypertension—Carmustine—melanoma	6.99e-05	0.00101	CcSEcCtD
Cyclosporine—Thrombocytopenia—Dactinomycin—melanoma	6.92e-05	0.000998	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Bleomycin—melanoma	6.9e-05	0.000996	CcSEcCtD
Cyclosporine—Chest pain—Carmustine—melanoma	6.9e-05	0.000995	CcSEcCtD
Cyclosporine—Myalgia—Carmustine—melanoma	6.9e-05	0.000995	CcSEcCtD
Cyclosporine—Anxiety—Carmustine—melanoma	6.87e-05	0.000992	CcSEcCtD
Cyclosporine—Cough—Temozolomide—melanoma	6.83e-05	0.000986	CcSEcCtD
Cyclosporine—Paraesthesia—Bleomycin—melanoma	6.8e-05	0.000982	CcSEcCtD
Cyclosporine—Weight increased—Docetaxel—melanoma	6.8e-05	0.000981	CcSEcCtD
Cyclosporine—Convulsion—Temozolomide—melanoma	6.78e-05	0.000979	CcSEcCtD
Cyclosporine—Weight decreased—Docetaxel—melanoma	6.76e-05	0.000976	CcSEcCtD
Cyclosporine—Hypertension—Temozolomide—melanoma	6.76e-05	0.000975	CcSEcCtD
Cyclosporine—Dyspnoea—Bleomycin—melanoma	6.75e-05	0.000974	CcSEcCtD
Cyclosporine—Anorexia—Dactinomycin—melanoma	6.73e-05	0.000972	CcSEcCtD
Cyclosporine—Pneumonia—Docetaxel—melanoma	6.7e-05	0.000967	CcSEcCtD
Cyclosporine—Confusional state—Carmustine—melanoma	6.67e-05	0.000962	CcSEcCtD
Cyclosporine—Myalgia—Temozolomide—melanoma	6.67e-05	0.000962	CcSEcCtD
Cyclosporine—Arthralgia—Temozolomide—melanoma	6.67e-05	0.000962	CcSEcCtD
Cyclosporine—Infestation NOS—Docetaxel—melanoma	6.66e-05	0.000961	CcSEcCtD
Cyclosporine—Infestation—Docetaxel—melanoma	6.66e-05	0.000961	CcSEcCtD
Cyclosporine—Anxiety—Temozolomide—melanoma	6.64e-05	0.000958	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	6.62e-05	0.000955	CcSEcCtD
Cyclosporine—Oedema—Carmustine—melanoma	6.61e-05	0.000954	CcSEcCtD
Cyclosporine—Discomfort—Temozolomide—melanoma	6.59e-05	0.00095	CcSEcCtD
Cyclosporine—Decreased appetite—Bleomycin—melanoma	6.58e-05	0.00095	CcSEcCtD
Cyclosporine—Infection—Carmustine—melanoma	6.57e-05	0.000948	CcSEcCtD
Cyclosporine—ABCG2—lymph node—melanoma	6.57e-05	0.0024	CbGeAlD
Cyclosporine—Acute coronary syndrome—Docetaxel—melanoma	6.57e-05	0.000948	CcSEcCtD
Cyclosporine—Renal failure—Docetaxel—melanoma	6.55e-05	0.000945	CcSEcCtD
Cyclosporine—Neuropathy peripheral—Docetaxel—melanoma	6.53e-05	0.000942	CcSEcCtD
Cyclosporine—Myocardial infarction—Docetaxel—melanoma	6.53e-05	0.000942	CcSEcCtD
Cyclosporine—Dry mouth—Temozolomide—melanoma	6.52e-05	0.000941	CcSEcCtD
Cyclosporine—Stomatitis—Docetaxel—melanoma	6.49e-05	0.000937	CcSEcCtD
Cyclosporine—Jaundice—Docetaxel—melanoma	6.49e-05	0.000937	CcSEcCtD
Cyclosporine—Pain—Bleomycin—melanoma	6.48e-05	0.000935	CcSEcCtD
Cyclosporine—Conjunctivitis—Docetaxel—melanoma	6.48e-05	0.000935	CcSEcCtD
Cyclosporine—Thrombocytopenia—Carmustine—melanoma	6.47e-05	0.000934	CcSEcCtD
Cyclosporine—ABCB1—mammalian vulva—melanoma	6.47e-05	0.00236	CbGeAlD
Cyclosporine—Confusional state—Temozolomide—melanoma	6.44e-05	0.00093	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Dactinomycin—melanoma	6.44e-05	0.000929	CcSEcCtD
Cyclosporine—CYP2D6—head—melanoma	6.43e-05	0.00235	CbGeAlD
Cyclosporine—Oedema—Temozolomide—melanoma	6.39e-05	0.000922	CcSEcCtD
Cyclosporine—Anaphylactic shock—Temozolomide—melanoma	6.39e-05	0.000922	CcSEcCtD
Cyclosporine—Infection—Temozolomide—melanoma	6.35e-05	0.000916	CcSEcCtD
Cyclosporine—Anorexia—Carmustine—melanoma	6.3e-05	0.000909	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Docetaxel—melanoma	6.3e-05	0.000909	CcSEcCtD
Cyclosporine—Epistaxis—Docetaxel—melanoma	6.28e-05	0.000907	CcSEcCtD
Cyclosporine—Nervous system disorder—Temozolomide—melanoma	6.27e-05	0.000904	CcSEcCtD
Cyclosporine—Thrombocytopenia—Temozolomide—melanoma	6.26e-05	0.000903	CcSEcCtD
Cyclosporine—Feeling abnormal—Bleomycin—melanoma	6.24e-05	0.000901	CcSEcCtD
Cyclosporine—Skin disorder—Temozolomide—melanoma	6.21e-05	0.000896	CcSEcCtD
Cyclosporine—Hyperhidrosis—Temozolomide—melanoma	6.18e-05	0.000891	CcSEcCtD
Cyclosporine—Decreased appetite—Dactinomycin—melanoma	6.14e-05	0.000886	CcSEcCtD
Cyclosporine—Fatigue—Dactinomycin—melanoma	6.09e-05	0.000879	CcSEcCtD
Cyclosporine—Anorexia—Temozolomide—melanoma	6.09e-05	0.000879	CcSEcCtD
Cyclosporine—Pain—Dactinomycin—melanoma	6.04e-05	0.000872	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Carmustine—melanoma	6.02e-05	0.000869	CcSEcCtD
Cyclosporine—Urticaria—Bleomycin—melanoma	6.02e-05	0.000868	CcSEcCtD
Cyclosporine—Haemoglobin—Docetaxel—melanoma	6.01e-05	0.000867	CcSEcCtD
Cyclosporine—Rhinitis—Docetaxel—melanoma	6e-05	0.000865	CcSEcCtD
Cyclosporine—Body temperature increased—Bleomycin—melanoma	5.99e-05	0.000864	CcSEcCtD
Cyclosporine—Hepatitis—Docetaxel—melanoma	5.98e-05	0.000863	CcSEcCtD
Cyclosporine—Haemorrhage—Docetaxel—melanoma	5.98e-05	0.000863	CcSEcCtD
Cyclosporine—Insomnia—Carmustine—melanoma	5.98e-05	0.000863	CcSEcCtD
Cyclosporine—Hypoaesthesia—Docetaxel—melanoma	5.95e-05	0.000859	CcSEcCtD
Cyclosporine—Paraesthesia—Carmustine—melanoma	5.94e-05	0.000857	CcSEcCtD
Cyclosporine—Pharyngitis—Docetaxel—melanoma	5.94e-05	0.000857	CcSEcCtD
Cyclosporine—Urinary tract disorder—Docetaxel—melanoma	5.91e-05	0.000852	CcSEcCtD
Cyclosporine—Dyspnoea—Carmustine—melanoma	5.89e-05	0.000851	CcSEcCtD
Cyclosporine—Somnolence—Carmustine—melanoma	5.88e-05	0.000848	CcSEcCtD
Cyclosporine—Connective tissue disorder—Docetaxel—melanoma	5.88e-05	0.000848	CcSEcCtD
Cyclosporine—Urethral disorder—Docetaxel—melanoma	5.86e-05	0.000846	CcSEcCtD
Cyclosporine—Feeling abnormal—Dactinomycin—melanoma	5.82e-05	0.00084	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Temozolomide—melanoma	5.82e-05	0.00084	CcSEcCtD
Cyclosporine—Insomnia—Temozolomide—melanoma	5.78e-05	0.000834	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Dactinomycin—melanoma	5.78e-05	0.000834	CcSEcCtD
Cyclosporine—Visual impairment—Docetaxel—melanoma	5.76e-05	0.000832	CcSEcCtD
Cyclosporine—Decreased appetite—Carmustine—melanoma	5.75e-05	0.000829	CcSEcCtD
Cyclosporine—Paraesthesia—Temozolomide—melanoma	5.74e-05	0.000828	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Carmustine—melanoma	5.71e-05	0.000824	CcSEcCtD
Cyclosporine—Dyspnoea—Temozolomide—melanoma	5.7e-05	0.000822	CcSEcCtD
Cyclosporine—Somnolence—Temozolomide—melanoma	5.68e-05	0.00082	CcSEcCtD
Cyclosporine—Pain—Carmustine—melanoma	5.65e-05	0.000816	CcSEcCtD
Cyclosporine—Constipation—Carmustine—melanoma	5.65e-05	0.000816	CcSEcCtD
Cyclosporine—Dyspepsia—Temozolomide—melanoma	5.62e-05	0.000812	CcSEcCtD
Cyclosporine—Abdominal pain—Dactinomycin—melanoma	5.58e-05	0.000806	CcSEcCtD
Cyclosporine—Body temperature increased—Dactinomycin—melanoma	5.58e-05	0.000806	CcSEcCtD
Cyclosporine—Hypersensitivity—Bleomycin—melanoma	5.58e-05	0.000805	CcSEcCtD
Cyclosporine—Decreased appetite—Temozolomide—melanoma	5.55e-05	0.000802	CcSEcCtD
Cyclosporine—Flushing—Docetaxel—melanoma	5.55e-05	0.000801	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Temozolomide—melanoma	5.52e-05	0.000796	CcSEcCtD
Cyclosporine—Fatigue—Temozolomide—melanoma	5.51e-05	0.000795	CcSEcCtD
Cyclosporine—Pain—Temozolomide—melanoma	5.46e-05	0.000788	CcSEcCtD
Cyclosporine—Constipation—Temozolomide—melanoma	5.46e-05	0.000788	CcSEcCtD
Cyclosporine—Feeling abnormal—Carmustine—melanoma	5.45e-05	0.000786	CcSEcCtD
Cyclosporine—Asthenia—Bleomycin—melanoma	5.43e-05	0.000784	CcSEcCtD
Cyclosporine—Angiopathy—Docetaxel—melanoma	5.43e-05	0.000783	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Carmustine—melanoma	5.41e-05	0.00078	CcSEcCtD
Cyclosporine—Mediastinal disorder—Docetaxel—melanoma	5.39e-05	0.000778	CcSEcCtD
Cyclosporine—Chills—Docetaxel—melanoma	5.37e-05	0.000774	CcSEcCtD
Cyclosporine—Pruritus—Bleomycin—melanoma	5.36e-05	0.000773	CcSEcCtD
Cyclosporine—Arrhythmia—Docetaxel—melanoma	5.34e-05	0.000771	CcSEcCtD
Cyclosporine—Alopecia—Docetaxel—melanoma	5.28e-05	0.000763	CcSEcCtD
Cyclosporine—Feeling abnormal—Temozolomide—melanoma	5.27e-05	0.00076	CcSEcCtD
Cyclosporine—Mental disorder—Docetaxel—melanoma	5.24e-05	0.000756	CcSEcCtD
Cyclosporine—Abdominal pain—Carmustine—melanoma	5.23e-05	0.000754	CcSEcCtD
Cyclosporine—Body temperature increased—Carmustine—melanoma	5.23e-05	0.000754	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Temozolomide—melanoma	5.22e-05	0.000754	CcSEcCtD
Cyclosporine—Malnutrition—Docetaxel—melanoma	5.21e-05	0.000751	CcSEcCtD
Cyclosporine—Hypersensitivity—Dactinomycin—melanoma	5.2e-05	0.000751	CcSEcCtD
Cyclosporine—Dysgeusia—Docetaxel—melanoma	5.1e-05	0.000736	CcSEcCtD
Cyclosporine—Urticaria—Temozolomide—melanoma	5.08e-05	0.000732	CcSEcCtD
Cyclosporine—Asthenia—Dactinomycin—melanoma	5.07e-05	0.000731	CcSEcCtD
Cyclosporine—Body temperature increased—Temozolomide—melanoma	5.05e-05	0.000729	CcSEcCtD
Cyclosporine—Abdominal pain—Temozolomide—melanoma	5.05e-05	0.000729	CcSEcCtD
Cyclosporine—Muscle spasms—Docetaxel—melanoma	5.01e-05	0.000722	CcSEcCtD
Cyclosporine—Hypersensitivity—Carmustine—melanoma	4.87e-05	0.000703	CcSEcCtD
Cyclosporine—Diarrhoea—Dactinomycin—melanoma	4.83e-05	0.000697	CcSEcCtD
Cyclosporine—Vomiting—Bleomycin—melanoma	4.82e-05	0.000695	CcSEcCtD
Cyclosporine—Anaemia—Docetaxel—melanoma	4.81e-05	0.000694	CcSEcCtD
Cyclosporine—Rash—Bleomycin—melanoma	4.78e-05	0.000689	CcSEcCtD
Cyclosporine—Dermatitis—Bleomycin—melanoma	4.77e-05	0.000689	CcSEcCtD
Cyclosporine—Asthenia—Carmustine—melanoma	4.74e-05	0.000685	CcSEcCtD
Cyclosporine—Hypersensitivity—Temozolomide—melanoma	4.71e-05	0.000679	CcSEcCtD
Cyclosporine—Leukopenia—Docetaxel—melanoma	4.66e-05	0.000673	CcSEcCtD
Cyclosporine—ABCB1—head—melanoma	4.63e-05	0.00169	CbGeAlD
Cyclosporine—Asthenia—Temozolomide—melanoma	4.58e-05	0.000662	CcSEcCtD
Cyclosporine—Cough—Docetaxel—melanoma	4.54e-05	0.000656	CcSEcCtD
Cyclosporine—Diarrhoea—Carmustine—melanoma	4.52e-05	0.000653	CcSEcCtD
Cyclosporine—Pruritus—Temozolomide—melanoma	4.52e-05	0.000652	CcSEcCtD
Cyclosporine—Convulsion—Docetaxel—melanoma	4.51e-05	0.000651	CcSEcCtD
Cyclosporine—Nausea—Bleomycin—melanoma	4.5e-05	0.000649	CcSEcCtD
Cyclosporine—Hypertension—Docetaxel—melanoma	4.49e-05	0.000649	CcSEcCtD
Cyclosporine—Vomiting—Dactinomycin—melanoma	4.49e-05	0.000648	CcSEcCtD
Cyclosporine—Rash—Dactinomycin—melanoma	4.45e-05	0.000643	CcSEcCtD
Cyclosporine—Myalgia—Docetaxel—melanoma	4.43e-05	0.00064	CcSEcCtD
Cyclosporine—Chest pain—Docetaxel—melanoma	4.43e-05	0.00064	CcSEcCtD
Cyclosporine—Arthralgia—Docetaxel—melanoma	4.43e-05	0.00064	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	4.4e-05	0.000635	CcSEcCtD
Cyclosporine—Dizziness—Carmustine—melanoma	4.37e-05	0.000631	CcSEcCtD
Cyclosporine—Diarrhoea—Temozolomide—melanoma	4.37e-05	0.000631	CcSEcCtD
Cyclosporine—Dry mouth—Docetaxel—melanoma	4.33e-05	0.000626	CcSEcCtD
Cyclosporine—Confusional state—Docetaxel—melanoma	4.28e-05	0.000618	CcSEcCtD
Cyclosporine—Anaphylactic shock—Docetaxel—melanoma	4.25e-05	0.000613	CcSEcCtD
Cyclosporine—Oedema—Docetaxel—melanoma	4.25e-05	0.000613	CcSEcCtD
Cyclosporine—Dizziness—Temozolomide—melanoma	4.23e-05	0.00061	CcSEcCtD
Cyclosporine—Infection—Docetaxel—melanoma	4.22e-05	0.000609	CcSEcCtD
Cyclosporine—Vomiting—Carmustine—melanoma	4.2e-05	0.000607	CcSEcCtD
Cyclosporine—Nausea—Dactinomycin—melanoma	4.2e-05	0.000606	CcSEcCtD
Cyclosporine—Rash—Carmustine—melanoma	4.17e-05	0.000602	CcSEcCtD
Cyclosporine—Nervous system disorder—Docetaxel—melanoma	4.17e-05	0.000601	CcSEcCtD
Cyclosporine—Dermatitis—Carmustine—melanoma	4.16e-05	0.000601	CcSEcCtD
Cyclosporine—Thrombocytopenia—Docetaxel—melanoma	4.16e-05	0.0006	CcSEcCtD
Cyclosporine—Headache—Carmustine—melanoma	4.14e-05	0.000598	CcSEcCtD
Cyclosporine—Skin disorder—Docetaxel—melanoma	4.13e-05	0.000596	CcSEcCtD
Cyclosporine—Vomiting—Temozolomide—melanoma	4.06e-05	0.000586	CcSEcCtD
Cyclosporine—Anorexia—Docetaxel—melanoma	4.05e-05	0.000584	CcSEcCtD
Cyclosporine—Rash—Temozolomide—melanoma	4.03e-05	0.000581	CcSEcCtD
Cyclosporine—Dermatitis—Temozolomide—melanoma	4.02e-05	0.000581	CcSEcCtD
Cyclosporine—Headache—Temozolomide—melanoma	4e-05	0.000578	CcSEcCtD
Cyclosporine—Nausea—Carmustine—melanoma	3.93e-05	0.000567	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Docetaxel—melanoma	3.87e-05	0.000559	CcSEcCtD
Cyclosporine—Insomnia—Docetaxel—melanoma	3.84e-05	0.000555	CcSEcCtD
Cyclosporine—Paraesthesia—Docetaxel—melanoma	3.82e-05	0.000551	CcSEcCtD
Cyclosporine—Nausea—Temozolomide—melanoma	3.8e-05	0.000548	CcSEcCtD
Cyclosporine—Dyspnoea—Docetaxel—melanoma	3.79e-05	0.000547	CcSEcCtD
Cyclosporine—Somnolence—Docetaxel—melanoma	3.78e-05	0.000545	CcSEcCtD
Cyclosporine—Dyspepsia—Docetaxel—melanoma	3.74e-05	0.00054	CcSEcCtD
Cyclosporine—Decreased appetite—Docetaxel—melanoma	3.69e-05	0.000533	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Docetaxel—melanoma	3.67e-05	0.000529	CcSEcCtD
Cyclosporine—Fatigue—Docetaxel—melanoma	3.66e-05	0.000529	CcSEcCtD
Cyclosporine—Constipation—Docetaxel—melanoma	3.63e-05	0.000524	CcSEcCtD
Cyclosporine—Pain—Docetaxel—melanoma	3.63e-05	0.000524	CcSEcCtD
Cyclosporine—Feeling abnormal—Docetaxel—melanoma	3.5e-05	0.000505	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Docetaxel—melanoma	3.47e-05	0.000501	CcSEcCtD
Cyclosporine—Abdominal pain—Docetaxel—melanoma	3.36e-05	0.000485	CcSEcCtD
Cyclosporine—Body temperature increased—Docetaxel—melanoma	3.36e-05	0.000485	CcSEcCtD
Cyclosporine—ABCB1—lymph node—melanoma	3.24e-05	0.00118	CbGeAlD
Cyclosporine—Hypersensitivity—Docetaxel—melanoma	3.13e-05	0.000452	CcSEcCtD
Cyclosporine—Asthenia—Docetaxel—melanoma	3.05e-05	0.00044	CcSEcCtD
Cyclosporine—Pruritus—Docetaxel—melanoma	3.01e-05	0.000434	CcSEcCtD
Cyclosporine—Diarrhoea—Docetaxel—melanoma	2.91e-05	0.00042	CcSEcCtD
Cyclosporine—Dizziness—Docetaxel—melanoma	2.81e-05	0.000405	CcSEcCtD
Cyclosporine—Vomiting—Docetaxel—melanoma	2.7e-05	0.00039	CcSEcCtD
Cyclosporine—Rash—Docetaxel—melanoma	2.68e-05	0.000387	CcSEcCtD
Cyclosporine—Dermatitis—Docetaxel—melanoma	2.68e-05	0.000386	CcSEcCtD
Cyclosporine—Headache—Docetaxel—melanoma	2.66e-05	0.000384	CcSEcCtD
Cyclosporine—Nausea—Docetaxel—melanoma	2.52e-05	0.000364	CcSEcCtD
Cyclosporine—ABCB11—Metabolism—PIK3CB—melanoma	1.62e-06	2.3e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—HRAS—melanoma	1.61e-06	2.28e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PHGDH—melanoma	1.61e-06	2.28e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—LUM—melanoma	1.61e-06	2.28e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PTGS2—melanoma	1.61e-06	2.28e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—FASN—melanoma	1.6e-06	2.27e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—FGF2—melanoma	1.6e-06	2.26e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CG—melanoma	1.59e-06	2.25e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.59e-06	2.25e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.58e-06	2.24e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—SLC5A5—melanoma	1.58e-06	2.24e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—HPSE—melanoma	1.58e-06	2.23e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—PIK3CA—melanoma	1.57e-06	2.23e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—VEGFA—melanoma	1.56e-06	2.21e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PIK3CB—melanoma	1.55e-06	2.2e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CD—melanoma	1.55e-06	2.2e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.55e-06	2.2e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CYP17A1—melanoma	1.55e-06	2.2e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CUBN—melanoma	1.55e-06	2.19e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—STAT3—melanoma	1.55e-06	2.19e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—NRAS—melanoma	1.54e-06	2.19e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—IL6—melanoma	1.54e-06	2.19e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PTGS2—melanoma	1.54e-06	2.18e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PPARG—melanoma	1.53e-06	2.17e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—ALB—melanoma	1.53e-06	2.17e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.53e-06	2.17e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.53e-06	2.17e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GNAQ—melanoma	1.52e-06	2.16e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CD44—melanoma	1.52e-06	2.16e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—TP53—melanoma	1.52e-06	2.16e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CYP17A1—melanoma	1.51e-06	2.14e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CG—melanoma	1.51e-06	2.14e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	1.51e-06	2.14e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MDM2—melanoma	1.49e-06	2.12e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—SDHD—melanoma	1.49e-06	2.12e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—BSG—melanoma	1.49e-06	2.12e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CSPG4—melanoma	1.49e-06	2.12e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.49e-06	2.12e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.48e-06	2.1e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MAPK3—melanoma	1.48e-06	2.09e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—ERBB2—melanoma	1.47e-06	2.09e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GNA11—melanoma	1.46e-06	2.07e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CYP1B1—melanoma	1.46e-06	2.07e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PPARG—melanoma	1.46e-06	2.07e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—HRAS—melanoma	1.46e-06	2.06e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PIK3CB—melanoma	1.45e-06	2.06e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CD4—melanoma	1.45e-06	2.06e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GPAM—melanoma	1.45e-06	2.05e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PTGS2—melanoma	1.44e-06	2.04e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MYC—melanoma	1.44e-06	2.04e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—FASN—melanoma	1.43e-06	2.03e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GNA11—melanoma	1.43e-06	2.02e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CYP17A1—melanoma	1.43e-06	2.02e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—AKT1—melanoma	1.42e-06	2.02e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CYP17A1—melanoma	1.41e-06	2e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—SLC5A5—melanoma	1.41e-06	2e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MAPK1—melanoma	1.41e-06	1.99e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—EGFR—melanoma	1.41e-06	1.99e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.4e-06	1.99e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PTEN—melanoma	1.4e-06	1.98e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CG—melanoma	1.4e-06	1.98e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—FASN—melanoma	1.4e-06	1.98e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CD—melanoma	1.4e-06	1.98e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.39e-06	1.98e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—IL6—melanoma	1.39e-06	1.97e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—ABCB1—melanoma	1.39e-06	1.97e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CG—melanoma	1.39e-06	1.96e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—ALB—melanoma	1.38e-06	1.95e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.38e-06	1.95e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—SLC5A5—melanoma	1.38e-06	1.95e-05	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—AKT1—melanoma	1.37e-06	1.94e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CDKN1B—melanoma	1.36e-06	1.93e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GNAQ—melanoma	1.36e-06	1.93e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CD44—melanoma	1.36e-06	1.93e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CB—melanoma	1.35e-06	1.92e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PPARG—melanoma	1.35e-06	1.91e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GNA11—melanoma	1.35e-06	1.91e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PTEN—melanoma	1.34e-06	1.9e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PTGS2—melanoma	1.34e-06	1.9e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PPARG—melanoma	1.34e-06	1.9e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GNA11—melanoma	1.33e-06	1.89e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.33e-06	1.89e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CD44—melanoma	1.33e-06	1.88e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GNAQ—melanoma	1.33e-06	1.88e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CD—melanoma	1.33e-06	1.88e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—KRAS—melanoma	1.33e-06	1.88e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.32e-06	1.87e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—FASN—melanoma	1.32e-06	1.87e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—ALB—melanoma	1.31e-06	1.86e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—FASN—melanoma	1.31e-06	1.85e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CYP1B1—melanoma	1.3e-06	1.85e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—SLC5A5—melanoma	1.3e-06	1.84e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.29e-06	1.83e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CTNNB1—melanoma	1.29e-06	1.83e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—SLC5A5—melanoma	1.28e-06	1.82e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—AKT1—melanoma	1.28e-06	1.82e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PRKCA—melanoma	1.28e-06	1.81e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CYP1B1—melanoma	1.27e-06	1.8e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—ERCC2—melanoma	1.27e-06	1.8e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CDKN1A—melanoma	1.26e-06	1.78e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PTEN—melanoma	1.26e-06	1.78e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GNAQ—melanoma	1.25e-06	1.77e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CD44—melanoma	1.25e-06	1.77e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GNAQ—melanoma	1.24e-06	1.76e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CD44—melanoma	1.24e-06	1.76e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PLA2G6—melanoma	1.23e-06	1.74e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CD—melanoma	1.23e-06	1.74e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PIK3CA—melanoma	1.22e-06	1.73e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CD—melanoma	1.22e-06	1.73e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CB—melanoma	1.22e-06	1.73e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.22e-06	1.72e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—ALB—melanoma	1.21e-06	1.72e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PTGS2—melanoma	1.21e-06	1.71e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.2e-06	1.71e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ABCB1—melanoma	1.2e-06	1.71e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—ALB—melanoma	1.2e-06	1.7e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CYP1B1—melanoma	1.2e-06	1.7e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CYP1B1—melanoma	1.19e-06	1.69e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TP53—melanoma	1.18e-06	1.67e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PTEN—melanoma	1.17e-06	1.66e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CB—melanoma	1.16e-06	1.64e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.15e-06	1.63e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PTGS2—melanoma	1.15e-06	1.62e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—HRAS—melanoma	1.13e-06	1.6e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—STAT3—melanoma	1.12e-06	1.59e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—NRAS—melanoma	1.12e-06	1.59e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PRKCA—melanoma	1.11e-06	1.57e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—VCAN—melanoma	1.1e-06	1.57e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ERCC2—melanoma	1.1e-06	1.56e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IL6—melanoma	1.08e-06	1.53e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ABCB1—melanoma	1.07e-06	1.52e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MAPK3—melanoma	1.07e-06	1.52e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CB—melanoma	1.07e-06	1.52e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CB—melanoma	1.06e-06	1.51e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PTGS2—melanoma	1.06e-06	1.5e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PTGS2—melanoma	1.05e-06	1.49e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PTEN—melanoma	1.05e-06	1.49e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.05e-06	1.49e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MYC—melanoma	1.04e-06	1.48e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MAPK1—melanoma	1.02e-06	1.45e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—EGFR—melanoma	1.02e-06	1.45e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CG—melanoma	1e-06	1.42e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PTEN—melanoma	1e-06	1.42e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—AKT1—melanoma	9.96e-07	1.41e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PRKCA—melanoma	9.89e-07	1.4e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ABCB1—melanoma	9.88e-07	1.4e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PIK3CA—melanoma	9.88e-07	1.4e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ERCC2—melanoma	9.81e-07	1.39e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ABCB1—melanoma	9.8e-07	1.39e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PPARG—melanoma	9.67e-07	1.37e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PRKCA—melanoma	9.65e-07	1.37e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—KRAS—melanoma	9.65e-07	1.37e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—ERCC2—melanoma	9.57e-07	1.36e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PIK3CA—melanoma	9.47e-07	1.34e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYP17A1—melanoma	9.32e-07	1.32e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PTEN—melanoma	9.26e-07	1.31e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PTEN—melanoma	9.18e-07	1.3e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.1e-07	1.29e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PRKCA—melanoma	9.09e-07	1.29e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ERCC2—melanoma	9.02e-07	1.28e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PRKCA—melanoma	9.02e-07	1.28e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ERCC2—melanoma	8.94e-07	1.27e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PIK3CA—melanoma	8.86e-07	1.26e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CD—melanoma	8.81e-07	1.25e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GNA11—melanoma	8.8e-07	1.25e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—ALB—melanoma	8.69e-07	1.23e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CG—melanoma	8.68e-07	1.23e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—FASN—melanoma	8.61e-07	1.22e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—SLC5A5—melanoma	8.47e-07	1.2e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PPARG—melanoma	8.37e-07	1.19e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CA—melanoma	8.25e-07	1.17e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—HRAS—melanoma	8.2e-07	1.16e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GNAQ—melanoma	8.18e-07	1.16e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CD44—melanoma	8.18e-07	1.16e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	8.12e-07	1.15e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—AKT1—melanoma	8.07e-07	1.14e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—IL6—melanoma	7.85e-07	1.11e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYP1B1—melanoma	7.85e-07	1.11e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CG—melanoma	7.74e-07	1.1e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—AKT1—melanoma	7.74e-07	1.1e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CB—melanoma	7.68e-07	1.09e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CD—melanoma	7.63e-07	1.08e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PTGS2—melanoma	7.61e-07	1.08e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CG—melanoma	7.56e-07	1.07e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ALB—melanoma	7.53e-07	1.07e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PPARG—melanoma	7.47e-07	1.06e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CA—melanoma	7.42e-07	1.05e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.41e-07	1.05e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PPARG—melanoma	7.3e-07	1.03e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—AKT1—melanoma	7.24e-07	1.03e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CG—melanoma	7.12e-07	1.01e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CG—melanoma	7.06e-07	1e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CA—melanoma	7.05e-07	1e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PPARG—melanoma	6.88e-07	9.74e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PPARG—melanoma	6.82e-07	9.66e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CD—melanoma	6.81e-07	9.65e-06	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—AKT1—melanoma	6.74e-07	9.55e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ALB—melanoma	6.72e-07	9.53e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CB—melanoma	6.65e-07	9.42e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CD—melanoma	6.65e-07	9.42e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PTEN—melanoma	6.63e-07	9.4e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PTGS2—melanoma	6.59e-07	9.34e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—ALB—melanoma	6.56e-07	9.3e-06	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CA—melanoma	6.53e-07	9.26e-06	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CA—melanoma	6.47e-07	9.17e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ABCB1—melanoma	6.46e-07	9.16e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CD—melanoma	6.26e-07	8.88e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CD—melanoma	6.21e-07	8.8e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ALB—melanoma	6.18e-07	8.76e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ALB—melanoma	6.13e-07	8.69e-06	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—AKT1—melanoma	6.06e-07	8.59e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PRKCA—melanoma	5.95e-07	8.43e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CB—melanoma	5.93e-07	8.41e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ERCC2—melanoma	5.9e-07	8.36e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PTGS2—melanoma	5.88e-07	8.33e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CB—melanoma	5.79e-07	8.21e-06	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—AKT1—melanoma	5.76e-07	8.17e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PTEN—melanoma	5.75e-07	8.14e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PTGS2—melanoma	5.74e-07	8.13e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CB—melanoma	5.46e-07	7.74e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CB—melanoma	5.41e-07	7.67e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PTGS2—melanoma	5.41e-07	7.67e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PTGS2—melanoma	5.36e-07	7.6e-06	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—AKT1—melanoma	5.34e-07	7.56e-06	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—AKT1—melanoma	5.29e-07	7.49e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PTEN—melanoma	5.13e-07	7.27e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PTEN—melanoma	5.01e-07	7.09e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PTEN—melanoma	4.72e-07	6.68e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CA—melanoma	4.68e-07	6.63e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PTEN—melanoma	4.68e-07	6.63e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CG—melanoma	4.66e-07	6.6e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PPARG—melanoma	4.5e-07	6.37e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CD—melanoma	4.09e-07	5.8e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CA—melanoma	4.05e-07	5.74e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ALB—melanoma	4.04e-07	5.73e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—AKT1—melanoma	3.82e-07	5.42e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CA—melanoma	3.62e-07	5.13e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CB—melanoma	3.57e-07	5.06e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PTGS2—melanoma	3.54e-07	5.01e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CA—melanoma	3.53e-07	5e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CA—melanoma	3.33e-07	4.72e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—AKT1—melanoma	3.31e-07	4.69e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CA—melanoma	3.3e-07	4.68e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PTEN—melanoma	3.08e-07	4.37e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—AKT1—melanoma	2.96e-07	4.19e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—AKT1—melanoma	2.88e-07	4.09e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—AKT1—melanoma	2.72e-07	3.85e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—AKT1—melanoma	2.69e-07	3.82e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CA—melanoma	2.18e-07	3.08e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—AKT1—melanoma	1.78e-07	2.52e-06	CbGpPWpGaD
